Microbot Non Current Assets Total vs Non Current Liabilities Total Analysis
MBOT Stock | USD 0.93 0.01 1.09% |
Microbot Medical financial indicator trend analysis is infinitely more than just investigating Microbot Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microbot Medical is a good investment. Please check the relationship between Microbot Medical Non Current Assets Total and its Non Current Liabilities Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.
Non Current Assets Total vs Non Current Liabilities Total
Non Current Assets Total vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microbot Medical Non Current Assets Total account and Non Current Liabilities Total. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Microbot Medical's Non Current Assets Total and Non Current Liabilities Total is 0.94. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Microbot Medical, assuming nothing else is changed. The correlation between historical values of Microbot Medical's Non Current Assets Total and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Microbot Medical are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Non Current Assets Total i.e., Microbot Medical's Non Current Assets Total and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.94 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Non Current Liabilities Total
Most indicators from Microbot Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 28.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.9 M in 2024.
Microbot Medical fundamental ratios Correlations
Click cells to compare fundamentals
Microbot Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Microbot Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 37.1M | 26.3M | 16.8M | 9.5M | 8.3M | 7.9M | |
Other Current Liab | 608K | 696K | 1.4M | 1.7M | 3.2M | 2.6M | |
Total Current Liabilities | 4.8M | 1.3M | 2.0M | 2.1M | 3.8M | 4.8M | |
Total Stockholder Equity | 31.5M | 24.3M | 14.4M | 7.3M | 4.5M | 4.3M | |
Property Plant And Equipment Net | 1.2M | 1.0M | 888K | 723K | 406K | 385.7K | |
Net Debt | (27.9M) | (18.8M) | (12.8M) | (2.0M) | (2.2M) | (2.3M) | |
Retained Earnings | (35.1M) | (44.3M) | (55.6M) | (68.8M) | (79.5M) | (83.5M) | |
Accounts Payable | 284K | 275K | 279K | 116K | 357K | 489.2K | |
Cash | 28.8M | 19.7M | 13.5M | 2.4M | 2.5M | 2.3M | |
Non Current Assets Total | 1.2M | 1.0M | 888K | 723K | 406K | 385.7K | |
Non Currrent Assets Other | 259K | 962K | 5.0K | (1.0) | (0.9) | (0.85) | |
Cash And Short Term Investments | 31.3M | 24.6M | 15.5M | 8.2M | 6.4M | 6.1M | |
Net Receivables | 101K | 340K | 174K | 103K | 1.3M | 1.4M | |
Common Stock Shares Outstanding | 4.3M | 7.1M | 7.1M | 7.3M | 10.2M | 10.7M | |
Liabilities And Stockholders Equity | 37.1M | 26.3M | 16.8M | 9.5M | 8.3M | 7.9M | |
Non Current Liabilities Total | 760K | 626K | 402K | 179K | 40K | 38K | |
Other Current Assets | 7.2M | 265K | 213K | 609K | 1.6M | 3.2M | |
Other Stockholder Equity | 66.6M | 68.5M | 69.9M | 76.0M | 83.9M | 88.1M | |
Total Liab | 5.6M | 2.0M | 2.4M | 2.2M | 3.8M | 3.6M | |
Total Current Assets | 35.9M | 25.3M | 15.9M | 8.8M | 7.9M | 7.5M | |
Property Plant And Equipment Gross | 1.2M | 251.0 | 1.2M | 1.1M | 899K | 854.1K | |
Common Stock Total Equity | 406K | 31K | 72K | 72.0 | 64.8 | 61.56 | |
Common Stock | 406K | 31K | 72K | 80K | 118K | 112.1K | |
Net Tangible Assets | 31.5M | 24.3M | 14.4M | 7.3M | 8.4M | 11.1M | |
Retained Earnings Total Equity | (20.6M) | (27.9M) | (35.1M) | (44.3M) | (50.9M) | (53.5M) | |
Capital Surpluse | 30.2M | 32.5M | 70.0M | 68.5M | 61.7M | 58.6M | |
Property Plant Equipment | 228K | 1.0M | 888K | 723K | 650.7K | 1.2M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.